Neurotechnology pain-relief device company SPR Therapeutics has increased its series A round of investment to $1 million and hopes to push the number up to $2 million, according to a regulatory ...

Neurostimulation startup SPR Therapeutics has reached an important milestone, implanting its post-stroke shoulder-pain device in a patient for the first time. A 76-year-old man suffering from shoulder ...

SPR Therapeutics has raised $25 million to commercialize its FDA-cleared nonopioid pain-relief device. The series C tees SPR up to push a neurostimulation technology it wants to position as a ...

SPR Therapeutics, a privately held medical device company, has dramatically expanded its headquarters office at Metropolitan Plaza in Highland Hills as it prepares to start hiring people as part of ...

"That gives us great confidence in our technology," Bennett said. Severe shoulder pain is common following a stroke; it affects roughly one-third of patients, manifesting in difficulty sleeping and ...

SPR Therapeutics is preparing to launch its pain relief device by the end of the year, pending final 510(k) clearance from the Food and Drug Administration, according to a Mass Device news report. SPR ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. SPR Therapeutics device uses electrical stimulation rather ...

CLEVELAND, OH--(Marketwired - Jul 28, 2016) - SPR® Therapeutics received clearance from the United States Food and Drug Administration to commercialize the SPRINT™ Peripheral Nerve Stimulation (PNS) ...